+44 115 7870500
DevelRx Logo
HomeTeam
Services
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact

Poster presentations - ADHD

Drug Abuse and DependenceADHDBinge-Eating DisorderPsychiatric and Neurological DisordersObesity and Metabolic Disorders

Gosden J, Slater NA, Heal DJ, Deats T, Hopkins SC, Koblan KS. Profile of dasotraline in rats trained to discriminate d-amphetamine from saline compared with various drugs used to treat ADHD. College on Problems of Drug Dependence Meeting, June 2018.

Heal DJ, Kulkarni RS, Pinder L, Rowley HL, Deats T, Hopkins SC, Koblan KS. Dasotraline is a monoamine reuptake inhibitor not a releasing agent as revealed by tetrodotoxin (TTX) sensitivity in microdialysis in the nucleus accumbens of freely-moving rats. College on Problems of Drug Dependence Meeting, June 2018.

Rowley HL, Kulkarni RS, Pinder L, Heal DJ, Deats T, Hopkins SC, Koblan KS. Dasotraline – Evaluation of its dopamine reuptake characteristics in comparison to stimulants and non-stimulants by microdialysis in the nucleus accumbens of freely-moving rats, Society for Neurosciences Congress, Nov 2017.

Pillidge K, Porter AJ, Tsai YC, Vasili T, Heal DJ, Stanford SC. Predictive validity of the neurokinin-1 knockout mouse model of ADHD. Society for Neurosciences Congress, Nov 2014.

DevelRx Logo

Biocity,

Pennyfoot Street,

Nottingham,

Nottinghamshire,

NG1 1GF

Legal

Cookie PolicyPrivacy PolicyTerms & Conditions
inform@develrx.com

Registered in England and Wales

Company number: 12028847